INNATE PHARMA
Ownership & governance
Executives 5Directors 8Avg age 56Avg tenure 4.8y
JD
Jonathan Dickinson
Chief Executive Officer
Since 2024-10-31
+12
Executives5
JD
Jonathan Dickinson
Chief Executive Officer
—Since 2024-10-31
FL
Frederic Lombard
Director of Finance/CFO
Age 51Since 2021-03-31
SQ
Sonia Quaratino
Chief Tech/Sci/R&D Officer
—Since 2023-10-31
OB
Odile Belzunce
Compliance Officer
Age 46Since 2019-01-30
YM
Yannis Morel
Chief Operating Officer
Age 52Since 2024-01-03
Board of directors8
IS
Irina Staatz-Granzer
Chairman
Age 66Since 2023-12-31
VC
Véronique Chabernaud
Director/Board Member
Age 64Since 2015-04-26
PB
Pascale Boissel
Director/Board Member
Age 59Since 2020-05-18
OM
Olivier Martinez
Director/Board Member
Age 52Since 2010-05-24
SB
Sally Bennett
Director/Board Member
Age 54Since 2022-05-19
JD
Jonathan Dickinson
Director/Board Member
—Since 2025-05-21
CI
Christian Itin
Director/Board Member
Age 61Since 2025-05-21
MD
Marty J. Duvall
Director/Board Member
—Since 2025-05-21
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| SANOFI | 8.885 % | 8,345,387 |
| ASTRAZENECA PLC | 8.332 % | 7,825,501 |
| BPIFrance Participations SA /PRIVATE EQUITY/ | 6.803 % | 6,389,406 |
| CDC Croissance SA | 0.9902 % | 930,023 |
| Yannis Morel | 0.4607 % | 432,692 |
Catalog · 2026-07-09
Registry officers1
| Name | Role | Since | Shares |
|---|---|---|---|
| Nicola Beltraminelli, Chief Development Officer | Membre du conseil d'administration | — | - |
Registry · as of 2026-01-05
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus noneMean target 5.9Range 5.6–6.2Analysts 2
5.6Mean 5.96.2
- Buy 2
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.